Does TOFACITINIB Cause Product dose omission in error? 2,461 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 2,461 reports of Product dose omission in error have been filed in association with TOFACITINIB (XELJANZ XR). This represents 1.6% of all adverse event reports for TOFACITINIB.
2,461
Reports of Product dose omission in error with TOFACITINIB
1.6%
of all TOFACITINIB reports
8
Deaths
189
Hospitalizations
How Dangerous Is Product dose omission in error From TOFACITINIB?
Of the 2,461 reports, 8 (0.3%) resulted in death, 189 (7.7%) required hospitalization, and 1 (0.0%) were considered life-threatening.
Is Product dose omission in error Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 2,461 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Product dose omission in error?
DUPILUMAB (7,586)
LENALIDOMIDE (618)
PALBOCICLIB (592)
DIROXIMEL (481)
ABALOPARATIDE (457)
NIRAPARIB (428)
RUXOLITINIB (425)
TERIFLUNOMIDE (371)
DIMETHYL (308)
RELUGOLIX (293)
Which TOFACITINIB Alternatives Have Lower Product dose omission in error Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN